Observational Study on the Clinical Use of ex Vivo Lung Perfusion (XPS™) for Lung Transplantation

NCT06795516 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 1

Last updated 2026-03-27

No results posted yet for this study

Summary

Clinical use of ex-vivo perfusion for lung transplantation. Collection, storage and processing of patient data for outcome analysis.

Conditions

  • Lung Transplantation

Sponsors & Collaborators

  • Hannover Medical School

    lead OTHER

Principal Investigators

  • Fabio Ius, Prof. Dr. · Hannover Medical School

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-01
Primary Completion
2026-03-03
Completion
2026-03-03

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06795516 on ClinicalTrials.gov